PNH and aHUS Market Share, Size & Demand by 2034

Coverage: by Type (PNH, AHUS); Application (Hospital, Clinics, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00013509
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : June 02, 2026
PNH and aHUS Market Share, Size & Demand by 2034
Report Date: June 02, 2026   |   Report Code: TIPRE00013509 Email: sales@theinsightpartners.com

2025 Market Size

US$ 5.9 Bn

Base year value

2034 Forecast

US$ 10.5 Bn

Projected by 2034

CAGR 2026-2034

6.61 %

Growth rate

Addressable Market

US$ 74.13 Bn

(2026-2034)

The PNH and aHUS Market size is expected to reach US$ 10.5 Billion by 2034 from US$ 5.9 Billion in 2025. The market is estimated to record a CAGR of 6.61% from 2026 to 2034.

The report is categorized by Type (PNH, AHUS) and further analyzes the market based on Application (Hospital, Clinics). A comprehensive breakdown is provided at global, regional, and country levels for each of these key segments. The report includes market size and forecasts across all segments, presenting values in USD. It also delivers key statistics on the current market status of leading players, along with insights into prevailing market trends and emerging opportunities.

Purpose of the Report

The report PNH and aHUS Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

PNH and aHUS Market Segmentation

Type

  1. PNH
  2. AHUS

Application

  1. Hospital
  2. Clinics

PNH and aHUS Market Growth Drivers

  1. Empowering Patients: Innovative Treatments for aHUS
  2. Transforming Lives: PNH Awareness and Support
  3. Driving Research: Advancements in aHUS and PNH Therapies

PNH and aHUS Market Future Trends

  1. Innovative therapies for PNH patients' quality of life
  2. Early diagnosis tools for aHUS to improve outcomes
  3. Personalized medicine approaches for targeted treatments

PNH and aHUS Market Opportunities

  1. Innovative Therapies Transforming PNH and aHUS Patient Lives
  2. Personalized Medicine: Tailoring Treatments for PNH and aHUS
  3. Community Support: Empowering Patients in PNH and aHUS Journeys

PNH and aHUS Market Report Scope

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the PNH and aHUS Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the PNH and aHUS Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.

PNH and aHUS Report Scope

Report Attribute Details
Market size in 2025 US$ 5.9 Billion
Market Size by 2034 US$ 10.5 Billion
Global CAGR (2026 - 2034) 6.61%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Type
  • PNH
  • AHUS
By Application
  • Hospital
  • Clinics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • AstraZeneca
  • Akari Therapeutics
  • Apellis Pharmaceuticals
  • Novartis
  • F. Hoffmann-La Roche
  • Regeneron Pharmaceuticals
  • Omeros Corporation
  • Generium
  • SanegeneBio
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA